Sab Biotherapeutics logo

Sab Biotherapeutics share price today

(SABS)

Sab Biotherapeutics share price is $4.65 & ₹395.14 as on 21 Dec 2024, 2.30 'hrs' IST

$4.65

0.75

(19.23%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Sab Biotherapeutics share price in Dollar and Rupees. Guide to invest in Sab Biotherapeutics from India. Also see the sentimental analysis on Indian investors investing in Sab Biotherapeutics. Get details on the Indian mutual funds that are investing in Sab Biotherapeutics. Get Analyst recommendations and forecasts along with all the Sab Biotherapeutics's financials.

Sab Biotherapeutics share price movements

  • Today's Low: $3.85
    Today's High: $4.70

    Day's Volatility :18.09%

  • 52 Weeks Low: $2.16
    52 Weeks High: $7.70

    52 Weeks Volatility :71.95%

Sab Biotherapeutics Returns

PeriodSab Biotherapeutics IncIndex (Russel 2000)
3 Months
30.0%
0.0%
6 Months
31.76%
0.0%
1 Year
-44.37%
0.0%
3 Years
-95.49%
-17.3%

Sab Biotherapeutics Key Statistics

in dollars & INR

Previous Close
$3.9
Open
$3.99
Today's High
$4.7
Today's Low
$3.85
Market Capitalization
$30.8M
Today's Volume
$209.9K
52 Week High
$7.7
52 Week Low
$2.16
Revenue TTM
$1.5M
EBITDA
$-46.9M
Earnings Per Share (EPS)
$-6.3
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.6%
Return On Equity TTM
-174.73%

How to invest in Sab Biotherapeutics from India?

It is very easy for Indian residents to invest directly in Sab Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sab Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sab Biotherapeutics or SABS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sab Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sab Biotherapeutics shares which would translate to 0.183 fractional shares of Sab Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Sab Biotherapeutics, in just a few clicks!

Returns in Sab Biotherapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sab Biotherapeutics investment value today

Current value as on today

₹1,35,762

Returns

₹35,762

(+35.76%)

Returns from Sab Biotherapeutics Stock

₹33,666 (false-33.67%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Sab Biotherapeutics

-8%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Sab Biotherapeutics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -8% less investors are searching Sab Biotherapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Sab Biotherapeutics

  • Bvf Inc

    9.94%

  • RTW INVESTMENTS, LLC

    6.88%

  • Marshall Wace Asset Management Ltd

    4.98%

  • Sessa Capital IM LP

    4.97%

  • Vanguard Group Inc

    2.99%

  • HB Wealth Management, LLC

    1.18%

Analyst Recommendation on Sab Biotherapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Sab Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Sab Biotherapeutics

What analysts predicted

Upside of 166.67%

Current:

$4.65

Target:

$12.40

Insights on Sab Biotherapeutics

  • Price Movement

    In the last 1 month, SABS stock has moved up by 27.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 944.57K → 263.13K (in $), with an average decrease of 72.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -5.02M → -10.34M (in $), with an average decrease of 43.5% per quarter
  • SABS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 81.4%
  • SABS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 116.0%
  • Price to Sales

    ForSABS every $1 of sales, investors are willing to pay $22.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Sab Biotherapeutics Financials in INR & Dollars

FY19Y/Y Change
Revenue
$3.4M
-
Net Income
$-9.4M
-
Net Profit Margin
-273.62%
-
FY20Y/Y Change
Revenue
$55.2M
↑ 1504.91%
Net Income
$20.1M
↓ 313.62%
Net Profit Margin
36.42%
↑ 310.04%
FY21Y/Y Change
Revenue
$60.9M
↑ 10.21%
Net Income
$-17.4M
↓ 186.71%
Net Profit Margin
-28.66%
↓ 65.08%
FY22Y/Y Change
Revenue
$23.9M
↓ 60.73%
Net Income
$-18.7M
↑ 7.43%
Net Profit Margin
-78.4%
↓ 49.74%
FY23Y/Y Change
Revenue
$2.2M
↓ 90.63%
Net Income
$-42.2M
↑ 125.14%
Net Profit Margin
-1.9K%
↓ 1806.1%
Q2 FY23Q/Q Change
Revenue
$85.5K
↓ 96.04%
Net Income
$-6.9M
↓ 12.62%
Net Profit Margin
-8.0K%
↓ 7681.71%
Q3 FY23Q/Q Change
Revenue
$1.3M
↑ 1381.98%
Net Income
$-5.1M
↓ 25.85%
Net Profit Margin
-402.59%
↑ 7643.54%
Q4 FY23Q/Q Change
Revenue
$305.0K
↓ 75.93%
Net Income
$-22.9M
↑ 347.97%
Net Profit Margin
-7.5K%
↓ 7091.16%
Q1 FY24Q/Q Change
Revenue
$944.6K
↑ 209.69%
Net Income
$-5.0M
↓ 78.01%
Net Profit Margin
-532.06%
↑ 6961.69%
Q2 FY24Q/Q Change
Revenue
$263.1K
↓ 72.14%
Net Income
$-7.3M
↑ 45.96%
Net Profit Margin
-2.8K%
↓ 2255.63%
FY19Y/Y Change
Profit
$3.4M
-
FY20Y/Y Change
Profit
$55.2M
↑ 1504.91%
FY21Y/Y Change
Profit
$59.2M
↑ 7.21%
FY22Y/Y Change
Profit
$20.6M
↓ 65.2%
FY23Y/Y Change
Profit
$-1.5M
↓ 107.31%
Q2 FY23Q/Q Change
Profit
$-806.7K
↓ 165.2%
Q3 FY23Q/Q Change
Profit
$281.9K
↓ 134.94%
Q4 FY23Q/Q Change
Profit
$-639.4K
↓ 326.8%
Q1 FY24Q/Q Change
Profit
$-1.0M
↑ 62.68%
Q2 FY24Q/Q Change
Profit
$-758.9K
↓ 27.04%
FY19Y/Y Change
Operating Cash Flow
$-9.2M
-
Investing Cash Flow
$-608.7K
-
Financing Cash Flow
$3.7M
-
FY20Y/Y Change
Operating Cash Flow
$10.0M
↓ 208.58%
Investing Cash Flow
$-12.7M
↑ 1989.98%
Financing Cash Flow
$9.0M
↑ 143.98%
FY21Y/Y Change
Operating Cash Flow
$3.8M
↓ 62.43%
Investing Cash Flow
$-10.9M
↓ 13.98%
Financing Cash Flow
$34.1M
↑ 279.85%
FY22Y/Y Change
Operating Cash Flow
$3.8M
↑ 0.0%
Investing Cash Flow
$-2.1M
↓ 80.9%
Financing Cash Flow
$34.1M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
$-4.9M
↓ 117.86%
Investing Cash Flow
$-22.7K
↓ 100.02%
Financing Cash Flow
$-363.8K
↓ 100.92%

Sab Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Sab Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sab Biotherapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sab Biotherapeutics Inc
27.45%
31.76%
-44.37%
-95.49%
-94.66%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sab Biotherapeutics Inc
NA
NA
NA
-3.64
-1.75
-0.79
NA
4.0
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sab Biotherapeutics Inc
Buy
$30.8M
-94.66%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

About Sab Biotherapeutics

sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.
Organization
Sab Biotherapeutics
Employees
57
CEO
Mr. Samuel J. Reich
Industry
Miscellaneous

Management People of Sab Biotherapeutics

NameTitle
Mr. Samuel J. Reich
CEO & Executive Chairman
Dr. Eddie Joe Sullivan Ph.D.
Co-Founder, President & Director
Ms. Christine E. Hamilton M.B.A.
Co-Founder & Independent Director
Dr. Christoph Bausch M.B.A., Ph.D.
Executive VP & COO
Dr. Alexandra Kropotova M.B.A., M.D.
Executive VP & Chief Medical Officer
Dr. Edward D. Hamilton D.V.M.
Co-Founder & Board Observer
Dr. Carlos N. Carillo Ph.D.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in Sab Biotherapeutics from India :

What is Sab Biotherapeutics share price today?

Sab Biotherapeutics share price today stands at $4.65, Open: $3.99 ; Previous Close: $3.90 ; High: $4.70 ; Low: $3.85 ; 52 Week High: $7.70 ; 52 Week Low: $2.16. The stock opens at $3.99, after a previous close of $3.90. The stock reached a daily high of $4.70 and a low of $3.85, with a 52-week high of $7.70 and a 52-week low of $2.16.

Can Indians buy Sab Biotherapeutics shares?

Yes, Indians can invest in the Sab Biotherapeutics (SABS) from India.

With INDmoney, you can buy Sab Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sab Biotherapeutics at zero transaction cost.

How can I buy Sab Biotherapeutics shares from India?

It is very easy to buy Sab Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sab Biotherapeutics be purchased?

Yes, you can buy fractional shares of Sab Biotherapeutics with INDmoney app.

What are the documents required to start investing in Sab Biotherapeutics stocks?

To start investing in Sab Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sab Biotherapeutics

Today’s highest price of Sab Biotherapeutics (SABS) is $4.70.

Today’s lowest price of Sab Biotherapeutics (SABS) is $3.85.

What is today's market capitalisation of Sab Biotherapeutics

Today's market capitalisation of Sab Biotherapeutics SABS is 30.8M

What is the 52 Week High and Low Range of Sab Biotherapeutics

  • 52 Week High

    $7.70

  • 52 Week Low

    $2.16

What are the historical returns of Sab Biotherapeutics?

  • 1 Month Returns

    27.45%

  • 3 Months Returns

    31.76%

  • 1 Year Returns

    -44.37%

  • 5 Years Returns

    -94.66%

Who is the Chief Executive Officer (CEO) of Sab Biotherapeutics

Mr. Samuel J. Reich is the current Chief Executive Officer (CEO) of Sab Biotherapeutics.